Insmed Inc Stock Buy Hold or Sell Recommendation

INSM Stock  USD 76.55  1.48  1.97%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Insmed Inc is 'Strong Buy'. The recommendation algorithm takes into account all of Insmed's available fundamental, technical, and predictive indicators you will find on this site.
  
Check out Insmed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note, we conduct extensive research on individual companies such as Insmed and provide practical buy, sell, or hold advice based on investors' constraints. Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Execute Insmed Buy or Sell Advice

The Insmed recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Insmed Inc. Macroaxis does not own or have any residual interests in Insmed Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Insmed's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell InsmedBuy Insmed
Strong Buy

Market Performance

InsignificantDetails

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Below AverageDetails

Economic Sensitivity

Follows the market closelyDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Insmed Inc has a Risk Adjusted Performance of 0.0248, Jensen Alpha of 0.1281, Total Risk Alpha of 0.3258, Sortino Ratio of 0.064 and Treynor Ratio of 0.0474
Macroaxis provides unbiased trade recommendations on Insmed that should be used to complement current analysts and expert consensus on Insmed Inc. Our advice engine determines the entity's potential to grow exclusively from the perspective of an investors' current risk tolerance and investing horizon. To make sure Insmed Inc is not overpriced, please check out all Insmed fundamentals, including its revenue, short ratio, current liabilities, as well as the relationship between the cash per share and market capitalization . Given that Insmed Inc has a number of shares shorted of 14.46 M, we strongly advise you to confirm Insmed Inc market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Insmed Trading Alerts and Improvement Suggestions

The company reported the previous year's revenue of 363.71 M. Net Loss for the year was (913.77 M) with profit before overhead, payroll, taxes, and interest of 277.96 M.
Insmed Inc currently holds about 554.87 M in cash with (683.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.62.
Insmed Inc has a frail financial position based on the latest SEC disclosures
Over 99.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Truist maintains Buy on Insmed stock, sees PAH data as positive - Investing.com

Insmed Returns Distribution Density

The distribution of Insmed's historical returns is an attempt to chart the uncertainty of Insmed's future price movements. The chart of the probability distribution of Insmed daily returns describes the distribution of returns around its average expected value. We use Insmed Inc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Insmed returns is essential to provide solid investment advice for Insmed.
Mean Return
0.05
Value At Risk
-3.49
Potential Upside
3.63
Standard Deviation
2.29
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Insmed historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Insmed Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument, such as Insmed, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Insmed Inc back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
Shares
Rtw Investments, Llc2024-12-31
M
Ameriprise Financial Inc2024-12-31
2.9 M
Fidelity International Ltd2024-12-31
2.6 M
William Blair Investment Management, Llc2024-12-31
2.4 M
Alliancebernstein L.p.2024-12-31
2.4 M
Macquarie Group Ltd2024-12-31
2.3 M
Franklin Resources Inc2024-12-31
2.2 M
T. Rowe Price Investment Management,inc.2024-12-31
M
Pictet Asset Manangement Sa2024-12-31
M
Vanguard Group Inc2024-12-31
18.2 M
Blackrock Inc2024-12-31
16 M
Note, although Insmed's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Insmed Cash Flow Accounts

202020212022202320242025 (projected)
Change In Cash45.3M184.0M357.3M(591.7M)72.7M76.3M
Free Cash Flow(226.2M)(370.6M)(410.3M)(549.5M)(705.8M)(670.5M)
Depreciation14.2M14.2M10.3M10.6M11.0M11.6M
Other Non Cash Items27.4M52.0M6.5M167.2M122.0M128.1M
Capital Expenditures6.8M7.3M9.9M13.3M21.9M23.0M
Net Income(294.1M)(434.7M)(481.5M)(749.6M)(913.8M)(868.1M)
End Period Cash Flow532.8M716.8M1.1B482.4M555.0M582.8M
Change To Inventory(21.2M)(17.5M)(1.7M)(13.6M)(17.0M)(17.9M)
Investments(6.8M)(50.3M)(34.6M)(205.1M)(583.2M)(554.0M)
Change Receivables(13.7M)2.7M(8.1M)(6.4M)(5.8M)(6.1M)
Change To Netincome27.0M36.2M71.0M46.3M53.2M28.4M

Insmed Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Insmed or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Insmed's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Insmed stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.13
β
Beta against Dow Jones0.82
σ
Overall volatility
2.27
Ir
Information ratio 0.06

Insmed Volatility Alert

Insmed Inc currently demonstrates below-average downside deviation. It has Information Ratio of 0.06 and Jensen Alpha of 0.13. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Insmed's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Insmed's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Insmed Fundamentals Vs Peers

Comparing Insmed's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Insmed's direct or indirect competition across all of the common fundamentals between Insmed and the related equities. This way, we can detect undervalued stocks with similar characteristics as Insmed or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Insmed's fundamental indicators could also be used in its relative valuation, which is a method of valuing Insmed by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Insmed to competition
FundamentalsInsmedPeer Average
Return On Equity-8.91-0.31
Return On Asset-0.29-0.14
Profit Margin(2.51) %(1.27) %
Operating Margin(2.35) %(5.51) %
Current Valuation13.3 B16.62 B
Shares Outstanding181 M571.82 M
Shares Owned By Insiders0.98 %10.09 %
Shares Owned By Institutions99.02 %39.21 %
Number Of Shares Shorted14.46 M4.71 M
Price To Earning(8.70) X28.72 X
Price To Book47.61 X9.51 X
Price To Sales38.10 X11.42 X
Revenue363.71 M9.43 B
Gross Profit277.96 M27.38 B
EBITDA(818.79 M)3.9 B
Net Income(913.77 M)570.98 M
Cash And Equivalents554.87 M2.7 B
Cash Per Share4.62 X5.01 X
Total Debt45.49 M5.32 B
Current Ratio5.93 X2.16 X
Book Value Per Share1.59 X1.93 K
Cash Flow From Operations(683.88 M)971.22 M
Short Ratio7.75 X4.00 X
Earnings Per Share(5.57) X3.12 X
Target Price95.66
Number Of Employees1.27 K18.84 K
Beta1.28-0.15
Market Capitalization13.86 B19.03 B
Total Asset2.03 B29.47 B
Retained Earnings(4.36 B)9.33 B
Working Capital1.32 B1.48 B
Current Asset28.15 M9.34 B
Current Liabilities3.89 M7.9 B
Note: Disposition of 18750 shares by Lewis William of Insmed at 22.76 subject to Rule 16b-3 [view details]

Insmed Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Insmed . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Insmed Buy or Sell Advice

When is the right time to buy or sell Insmed Inc? Buying financial instruments such as Insmed Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Insmed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Agriculture Thematic Idea Now

Agriculture
Agriculture Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Agriculture theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Agriculture Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out Insmed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.57)
Revenue Per Share
2.217
Quarterly Revenue Growth
0.248
Return On Assets
(0.29)
Return On Equity
(8.91)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.